J. Liu et al. / Journal of Organometallic Chemistry 691 (2006) 2686–2690
2689
Table 3
1H NMR spectra data for compounds 4
Entry
R
1H NMR(d)
4a
Ph
3.88 (s, 2H, C5H4), 4.30 (s, 5H, C5H5), 4.56 (s, 2H, C5H4), 7.25 (s, 1H, @CH), 7.28–8.00 (m, 5H, Ar), 8.10 (s, 1H, TrH), 8.30 (s,
1H, TrH)
4b
4c
4d
4e
4f
p-ClPh
3.76 (s, 2H, C5H4), 4.16 (s, 5H, C5H5), 4.45 (s, 2H, C5H4), 7.18 (s, 1H, @CH), 7.33 (d, 2H, ArH), 7.52 (d, 2H, ArH), 7.86 (s,
1H, TrH), 8.21 (s, 1H, TrH)
3.86 (s, 2H, C5H4), 4.26 (s, 5H, C5H5), 4.56 (s, 2H, C5H4), 7.26 (s, 1H, @CH), 7.36 (d, 2H, ArH), 7.73 (d, 2H, ArH), 8.33 (s,
1H, TrH), 8.47 (s, 1H, TrH)
3.92 (s, 2H, C5H4), 4.33 (s, 5H, C5H5), 4.59 (s, 2H, C5H4), 7.36 (s, 1H, @CH), 7.76 (s, 4H, ArH), 7.56 (s, 1H, TrH), 8.02 (s, 1H,
TrH)
3.86 (s, 1H, C5H4), 4.26 (s, 5H, C5H5), 4.56 (s, 2H, C5H4), 7.26 (s, 1H, @CH), 7.52–8.13 (m, 4H, ArH), 8.33 (s, 1H, TrH), 8.67
(s, 1H, TrH),
2.45 (s, 3H, CH3), 3.89 (s, 2H, C5H4), 4.33 (s, 5H, C5H5), 4.59 (s, 2H, C5H4), 7.33–7.60 (m, 5H, @CH, ArH), 7.66 (s, 1H, TrH),
8.30 (s, 1H, TrH)
3.86 (s, 3H, OCH3), 3.89 (s, 2H, C5H4), 4.26 (s, 5H, C5H5), 4.53 (s, 2H, C5H4), 7.12 (d, 2H, ArH), 7.38 (s, 1H, @CH), 7.78 (d,
2H, ArH), 7.66 (s, 1H, TrH), 8.30 (s, 1H, TrH)
3.86 (s, 3H, OCH3), 3.89 (s, 2H, C5H4), 4.26 (s, 5H, C5H5), 4.53 (s, 2H, C5H4), 7.12 (d, 2H, ArH), 7.38 (s, 1H, @CH), 7.78
(d,2H, ArH), 7.66 (s, 1H, TrH), 8.30 (s, 1H, TrH)
2.50 (s, 3H, OCH3), 3.89 (s, 2H, C5H4), 4.33 (s, 5H, C5H5), 4.59 (s, 2H, C5H4), 7.41 (s, 1H, @CH), 7.53 (s, 1H, ArH), 7.56 (s,
1H, TrH), 8.36 (s, 1H, TrH)
3.86 (s, 2H, C5H4), 4.28 (s, 5H, C5H5), 4.51 (s, 2H, C5H4), 7.84–7.93 (m, 3H, PyH) 8.635, 8.649 (s, 1H, PyH), 8.43 (s, 1H,
@CH), 8.18 (s, 1H, TrH), 8.22 (s, 1H, TrH)
3.84 (s, 2H, C5H4), 4.25 (s, 5H, C5H5), 4.55 (s, 2H, C5H4), 7.71 (s, 1H, @CH), 7.415–8.00 (3H, m, PyH), 8.952 (s, 1H, PyH),
8.15 (s, 1H, TrH), 8.24 (s, 1H, TrH)
3.68 (s, 2H, C5H4), 4.16 (s, 5H, C5H5), 4.24 (s, 2H, C5H4), 7.25–7.53 (3H, m, ArH), 7.36 (s, 1H, @CH), 8.13 (s, 1H, TrH), 7.82
(s, 1H, TrH)
3.80 (s, 2H, C5H4), 4.54 (s, 5H, C5H5), 4.57 (s, 2H, C5H4), 7.38–7.82 (2H, m, ArH), 7.47 (s, 1H, ArH), 7.71 (s, 1H, @CH), 8.17
(s, 1H, TrH), 8.21 (s, 1H,TrH)
3.84 (s, 2H, C5H4), 4.45 (s, 5H, C5H5), 4.54 (s, 2H, C5H4), 7.50–7.58 (2H, m, ArH) 7.84 (s, 1H, ArH), 7.65 (s, 1H, @CH), 8.13
(s, 1H, TrH), 8.23 (s, 1H, TrH)
3.83 (s, 2H, C5H4), 4.50 (s, 5H, C5H5), 4.52 (s, 2H, C5H4), 7.16–7.20 (m, 2H, ArH), 7.72–7.78 (m, 2H, ArH), 7.63 (s, 1H,
@CH), 8.15 (s, 1H, TrH), 8.22 (s, 1H, TrH)
3.45 (s, 2H, C5H4), 4.25 (s, 5H, C5H5), 4.56 (s, 2H, C5H4), 7.26–7.42 (3H, m, ArH), 7.748 (s, 1H, @CH), 8.17 (s, 1H, TrH), 8.22
(s, 1H, TrH)
p-BrPh
m-BrPh
m-NO2Ph
m-CH3Ph
o-CH3Ph
p-CH3O-Ph(Z)
p-CH3O-Ph(E)
2-Pydine
3-Pydine
2.4-F2Ph
2.4-Cl2Ph
3.4-Cl2Ph
4-FPh
4g
4h
4i
4j
4k
4l
4m
4n
4o
4p
4q
2.5-Cl2Ph
2.5-(CH3-O)2Ph 3.79 (6H, m, OCH3), 3.81 (s, 2H, C5H4), 4.21 (s, 5H, C5H5), 4.78 (s, 2H, C5H4), 6.88–7.01 (3H, m, ArH) 7.53 (s, 1H, @CH),
8.15 (s, 1H, TrH), 8.16 (s, 1H,TrH)
¨
(c) H. YUksek, A. Demirbs, A. Ikizler, C.B. Johansson, C. Celik,
2-(1H-1,2,4-triazol-1-yl)1-ferrocenyl-3-aryl-prop-2-en-1-one
derivatives 4 in various yields. The physical properties, ele-
mental analysis data and 1H NMR spectra of compounds 4
thus synthesized were listed in the Tables 2 and 3,
respectively.
A.A. Ikizler, Arzn.-Forsh, Drug Res. 47 (1997) 405–409;
(d) A.A. Ikizler, F. ucar, N. Demirbas, I. Yasa, A. Ikizler, T. Genzer,
Indian J. Hetero. Chem. 61 (1999) 271–274.
[4] N. Demirbs, A. Ugurluoglu Demirbas, Bioorg. Med. Chem. 10 (2002)
3717–3723.
[5] G. Turan-Zitouni, Z.A. Kaplancikli, K. Erol, F.S. Killic, II Farmaco
54 (1999) 218–223.
[6] H. Emilsson, H. Salender, J. Gaarder, Eur. J. Med. Chem. Chim.
Ther. 21 (1985) 333–338.
Acknowledgements
We gratefully acknowledge the National Natural Sci-
ence Foundation of China (NNSFC) (No. 29872022,
20172030) and the Research Fund for the Doctoral pro-
gram of High Education (RFDP) (No. 9805520) for finan-
cial support.
[7] (a) M. Moreno-Manas, Y. Arredondo, R. Pleixats, M. Teixido,
M.M. Haga, C. Palacin, J.M. Castello, J.A. Oritizz, J. Hetero. Chem.
29 (1992) 1557;
(b) L. Czollner, G. Sxilagli, J. Janaky, Arch. Pharm. (Weinheim,
Ger.) 323 (1990) 225;
(c) C.H. Chu, X.W. Sun, L. Sun, Z.Y. Zhang, Z.C. Li, R.A. Liao, J.
Chin. Chem. Soc. 46 (1999) 229;
(d) A. Er-Rhaimini, R. Mornet, Indian J. Hetero. Chem. 29 (1992)
1561;
References
(e) H.L. EIbe, K.H. Buechel, W. Brandes, S. Dutzmann, K. Luerssen,
Ger offen, 4, 803,883 (Chem. Abstr) vol. 124, 1996, p. 261076;
(f) B. Wolfgan, R. Wolfgan, P. Arbold, S. Bartel, Ger. Offen DE.
4,425,660 (Chem. Abstr), vol. 124, 1996, p. 261076;
(g) Y. Liu, A. Gangguly, F. Bennet, JP 10: 231,296 (Chem. Abstr),
vol. 129, 1998, p. 260464.
¨
[1] B. Tozkoparan, N. GOkhan, G. Aktay, E. Yesilada, M. Ertan, Eur.
J. Med. Chem. 34 (2000) 743–750.
[2] M. kritsanida, A. Mouroutsou, P. Marakos, N. Pouli, S. Papakon-
stantinou-Garoufalias, C. Pannecouque, M. Witvouw, E.De. Clercq,
II Farmaco 57 (2002) 253–257.
[3] (a) B.S. Holla, R. Gonsalves, S. Shenoy, II Farmaco 53 (1998) 574–
578;
[8] (a) E.I. Edwards, R. Epton, G. Marr, J. Organomet. Chem. 85 (1975)
C23;
(b) S. Ersan, S. Nacak, R. Berkem, II Farmaco 53 (1998) 773–776;
(b) B.W. Rockeet, G. Marr, J. Organomet. Chem. 123 (1976) 205;